Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-02-21 Sale |
2024-02-22 4:32 pm |
Voyager Therapeutics Inc. | VYGR | PFREUNDSCHUH PETER P. Chief Financial Officer |
3,764 | $7.46 | $28,079 | 175,669 (Direct) |
View |
| 2023-10-03 Sale |
2023-10-05 4:41 pm |
Voyager Therapeutics Inc. | VYGR | PFREUNDSCHUH PETER P. Chief Financial Officer |
13,567 | $6.99 | $94,833 | 149,433 (Direct) |
View |
| 2022-02-18 Sale |
2022-02-23 4:38 pm |
Frequency Therapeutics Inc. | FREQ | PFREUNDSCHUH PETER P. Chief Financial Officer |
2,946 | $3.6948 | $10,885 | 8,927 (Direct) |
View |
| 2022-02-16 Sale |
2022-02-18 4:14 pm |
Frequency Therapeutics Inc. | FREQ | PFREUNDSCHUH PETER P. Chief Financial Officer |
2,525 | $4.3115 | $10,886 | 161,873 (Direct) |
View |
| 2022-02-15 Sale |
2022-02-16 4:59 pm |
Frequency Therapeutics Inc. | FREQ | PFREUNDSCHUH PETER P. Chief Financial Officer |
1,347 | $4.331 | $5,834 | 29,398 (Direct) |
View |
| 2020-10-15 Sale |
2020-10-16 3:41 pm |
UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. Chief Financial Officer |
2,400 | $21.77 | $52,248 | 18,154 (Direct) |
View |
| 2020-09-01 Sale |
2020-09-01 2:37 pm |
UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. Chief Financial Officer |
509 | $22.82 | $11,615 | 12,054 (Direct) |
View |
| 2020-07-27 Sale |
2020-07-28 5:34 pm |
UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. Chief Financial Officer |
141 | $23.51 | $3,315 | 9,855 (Direct) |
View |
| 2020-05-20 Sale |
2020-05-20 4:44 pm |
UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. Chief Financial Officer |
358 | $25.07 | $8,975 | 12,287 (Direct) |
View |
| 2020-04-27 Sale |
2020-04-28 1:51 pm |
UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. Chief Financial Officer |
141 | $24.35 | $3,433 | 9,313 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-17 Option Award |
2025-01-22 7:05 pm |
N/A 2035-01-17 |
Y-mAbs Therapeutics Inc. | YMAB | PFREUNDSCHUH PETER P. CFO and Treasurer |
95,300 | $0 | 141,300 (Direct) |
View |
| 2024-07-12 Option Award |
2024-07-12 5:29 pm |
N/A 2034-07-12 |
Y-mAbs Therapeutics Inc. | YMAB | PFREUNDSCHUH PETER P. CFO and Treasurer |
216,000 | $0 | 216,000 (Direct) |
View |
| 2024-02-09 Option Award |
2024-02-16 4:58 pm |
N/A 2034-02-09 |
Voyager Therapeutics Inc. | VYGR | PFREUNDSCHUH PETER P. Chief Financial Officer |
90,000 | $0 | 239,433 (Direct) |
View |
| 2023-02-17 Option Award |
2023-02-22 8:55 pm |
N/A 2033-02-17 |
Voyager Therapeutics Inc. | VYGR | PFREUNDSCHUH PETER P. Chief Financial Officer |
114,000 | $0 | 239,000 (Direct) |
View |
| 2022-10-01 Option Award |
2022-10-04 4:15 pm |
N/A N/A |
Voyager Therapeutics Inc. | VYGR | PFREUNDSCHUH PETER P. Chief Financial Officer |
125,000 | $0 | 125,000 (Direct) |
View |
| 2022-09-19 Option Award |
2022-09-21 4:41 pm |
N/A 2032-09-19 |
Voyager Therapeutics Inc. | VYGR | PFREUNDSCHUH PETER P. Chief Financial Officer |
200,000 | $0 | 200,000 (Direct) |
View |
| 2022-02-17 Option Award |
2022-02-18 4:14 pm |
N/A N/A |
Frequency Therapeutics Inc. | FREQ | PFREUNDSCHUH PETER P. Chief Financial Officer |
150,000 | $0 | 161,873 (Direct) |
View |
| 2022-02-14 Exercise |
2022-02-16 4:59 pm |
N/A N/A |
Frequency Therapeutics Inc. | FREQ | PFREUNDSCHUH PETER P. Chief Financial Officer |
15,000 | $0 | 29,398 (Direct) |
View |
| 2021-04-20 Option Award |
2021-04-22 4:22 pm |
N/A N/A |
Frequency Therapeutics Inc. | FREQ | PFREUNDSCHUH PETER P. Chief Financial Officer |
30,000 | $0 | 30,000 (Direct) |
View |
| 2021-01-15 Option Award |
2021-01-19 4:48 pm |
N/A 2031-01-14 |
Frequency Therapeutics Inc. | FREQ | PFREUNDSCHUH PETER P. Chief Financial Officer |
10,000 | $0 | 10,000 (Direct) |
View |
| 2020-12-02 Option Award |
2020-12-03 5:44 pm |
N/A 2030-12-01 |
Frequency Therapeutics Inc. | FREQ | PFREUNDSCHUH PETER P. Chief Financial Officer |
230,000 | $0 | 230,000 (Direct) |
View |
| 2020-10-15 Exercise |
2020-10-16 3:41 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. Chief Financial Officer |
9,834 | $0 | 18,154 (Direct) |
View |
| 2020-09-01 Exercise |
2020-09-01 2:37 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. Chief Financial Officer |
1,042 | $0 | 12,054 (Direct) |
View |
| 2020-07-26 Exercise |
2020-07-28 5:34 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. Chief Financial Officer |
417 | $0 | 9,855 (Direct) |
View |
| 2020-05-20 Exercise |
2020-05-20 4:44 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. Chief Financial Officer |
1,041 | $0 | 12,287 (Direct) |
View |
| 2020-04-26 Exercise |
2020-04-28 1:51 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. Chief Financial Officer |
417 | $0 | 9,313 (Direct) |
View |